Back to Search
ROBERT SCHLOSSMAN, MD
MD
Medical Oncology Physician
NPI: 1326001215Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
75562(MA)
Research & Publications (20)
Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
PMID 19584292·Cancer Res·2009
7-preclinical
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.
PMID 19528374·J Clin Oncol·2009
8-other
Bortezomib in the front-line treatment of multiple myeloma.
PMID 18588451·Expert Rev Anticancer Ther·2008
6-review
Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws.
PMID 18417376·Oral Surg Oral Med Oral Pathol Oral Radiol Endod·2008
5-case
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.
PMID 18413829·Clin Cancer Res·2008
8-other
High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.
PMID 17241924·Biol Blood Marrow Transplant·2007
1-meta
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study.
PMID 17138816·Blood·2007
8-other
The treatment of relapsed and refractory multiple myeloma.
PMID 18024646·Hematology Am Soc Hematol Educ Program·2007
6-review
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
PMID 17947482·Clin Cancer Res·2007
3-trial
Novel therapeutic avenues in myeloma: changing the treatment paradigm.
PMID 17722741·Oncology (Williston Park)·2007
6-review
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
PMID 17016430·Oncogene·2007
8-other
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
PMID 16818641·Cancer Res·2006
8-other
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma.
PMID 16840727·Blood·2006
3-trial
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.
PMID 16131571·Blood·2005
3-trial
Emerging trends in the clinical use of bortezomib in multiple myeloma.
PMID 16231845·Clin Lymphoma Myeloma·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 BROOKLINE AVE, M229
BOSTON, MA 02215 - Phone
- (613) 632-5126
Quick Facts
- NPI
- 1326001215
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile